Executive readout · one minute
Call research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
AUTL
$1.92
-1.29%
AUTL
· Autolus Therapeutics plc
Market Cap
$493.73M
Shares
266.16M
Volume · Oct 1
903K
Avg daily vol (3M)
2.04M
All earnings calls
Earnings call · FY2026 Q2
Autolus Therapeutics plc (AUTL) Q2 2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue
$45.69M
+118.4% YoY
Diluted EPS
-$0.15
Net income
-$39.11M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 11, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
AUCATZYL net product revenue
Initiated
full year 2026
|
$140M – $150M | — |
Quarter detail
How the reported period landed and where the business moved.
Company presentation
Slides
35 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 11, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 11, 2026 · complete as-filed document